From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Number of hospitalizations
Inpatient stays (days)
pre-PP1M
0.67 ± 0.96
52.80 ± 60.54
Post-PP1M
0.22 ± 0.42
16.33 ± 29.48
T
2.56
1.73
P
≤ 0.01
<0.05